BR112012017473A2 - pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos - Google Patents

pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos

Info

Publication number
BR112012017473A2
BR112012017473A2 BR112012017473A BR112012017473A BR112012017473A2 BR 112012017473 A2 BR112012017473 A2 BR 112012017473A2 BR 112012017473 A BR112012017473 A BR 112012017473A BR 112012017473 A BR112012017473 A BR 112012017473A BR 112012017473 A2 BR112012017473 A2 BR 112012017473A2
Authority
BR
Brazil
Prior art keywords
pyrido
pyrimidines
compounds
well
pharmaceutical composition
Prior art date
Application number
BR112012017473A
Other languages
English (en)
Portuguese (pt)
Inventor
Genovesio Auguste
Phillippe Cedric Fenistein Denis
Kim Eunhye
Park Eunjung
Anne Ewann Fanny
Jeon Heekyoung
Kim Jaeseung
Heo Jamung
Youn Nam Ji
Cechetto Jonathan
Jung Seo Min
Contreras Dominguez Monica
Brodin Priscille
Lee Saeyeon
Kang Sunhee
Christophe Thierry
No Zaesung
Original Assignee
Institut National De La Sante Et De La Rech Medicale Inserm Epst
Pasteur Institut Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Sante Et De La Rech Medicale Inserm Epst, Pasteur Institut Korea filed Critical Institut National De La Sante Et De La Rech Medicale Inserm Epst
Publication of BR112012017473A2 publication Critical patent/BR112012017473A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR112012017473A 2010-01-13 2011-01-13 pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos BR112012017473A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29455210P 2010-01-13 2010-01-13
PCT/EP2011/000135 WO2011085990A1 (en) 2010-01-13 2011-01-13 Anti - infective pyrido (1,2 -a) pyrimidines

Publications (1)

Publication Number Publication Date
BR112012017473A2 true BR112012017473A2 (pt) 2019-09-24

Family

ID=43610218

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012017473A BR112012017473A2 (pt) 2010-01-13 2011-01-13 pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos

Country Status (9)

Country Link
US (1) US20130012506A1 (pt-PT)
EP (1) EP2523956A1 (pt-PT)
JP (1) JP2013517233A (pt-PT)
KR (1) KR20130088002A (pt-PT)
CN (1) CN102812023A (pt-PT)
AU (1) AU2011206761A1 (pt-PT)
BR (1) BR112012017473A2 (pt-PT)
CA (1) CA2786329A1 (pt-PT)
WO (1) WO2011085990A1 (pt-PT)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014019750B1 (pt) * 2012-02-10 2020-03-03 F. Hoffmann-La Roche Ag. Composto, composição farmacêutica e seus usos
JP6092264B2 (ja) 2012-03-01 2017-03-08 ピーティーシー セラピューティクス， インコーポレイテッド 脊髄性筋委縮症を処置するための化合物
CA2868026C (en) 2012-03-23 2021-02-16 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
EP3227292B1 (en) * 2014-12-02 2022-03-09 Alterity Therapeutics Limited 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
CN105153151A (zh) * 2015-08-28 2015-12-16 张文莲 一种嘧啶酮类化合物的合成方法
WO2017100726A1 (en) 2015-12-10 2017-06-15 Ptc Therapeutics, Inc. Methods for treatng huntington's disease
EP3544435A4 (en) 2016-11-28 2020-11-04 PTC Therapeutics, Inc. RNA SPLICE MODULATION PROCESSES
AU2018282154B2 (en) 2017-06-05 2022-04-07 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
WO2018232039A1 (en) 2017-06-14 2018-12-20 Ptc Therapeutics, Inc. Methods for modifying rna splicing
CA3067592A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
SG11202009212WA (en) 2018-03-27 2020-10-29 Ptc Therapeutics Inc Compounds for treating huntington's disease
EP3814360A1 (en) 2018-06-27 2021-05-05 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
KR20210042265A (ko) 2018-06-27 2021-04-19 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료를 위한 헤테로사이클릭 및 헤테로아릴 화합물
CN114106000B (zh) * 2021-12-15 2023-11-24 中国科学院新疆理化技术研究所 一种咪唑并[4,5-d]嘧啶酮三环类衍生物及抗肿瘤用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US4957773A (en) 1989-02-13 1990-09-18 Syracuse University Deposition of boron-containing films from decaborane
WO2001058876A1 (fr) * 2000-02-09 2001-08-16 Daiichi Pharmaceutical Co., Ltd. Agents antibacteriens acidoresistants renfermant des acides pyridonecarboxyliques comme principe actif
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CN102105470B (zh) * 2008-06-17 2014-06-04 韩国巴斯德研究所 作为抗结核病药的吡啶并嘧啶化合物
WO2010001366A1 (en) * 2008-07-04 2010-01-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Piperazines derivatives as proteasome modulators

Also Published As

Publication number Publication date
CA2786329A1 (en) 2011-07-21
WO2011085990A8 (en) 2012-10-26
WO2011085990A1 (en) 2011-07-21
KR20130088002A (ko) 2013-08-07
CN102812023A (zh) 2012-12-05
EP2523956A1 (en) 2012-11-21
AU2011206761A1 (en) 2012-07-12
US20130012506A1 (en) 2013-01-10
JP2013517233A (ja) 2013-05-16
AU2011206761A2 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
BR112012017473A2 (pt) pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
MX2012010671A (es) Compuestos antiinfecciosos.
CO6680667A2 (es) Derivados ester de ácido borónico cíclico y sus usos terapéuticos
BR112013025987A2 (pt) derivados de pirimidina para o tratamento de infecções virais
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
CL2008001122A1 (es) Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
WO2010003533A3 (en) Pyridopyrimidine compounds as anti-tubercular agents
ZA201307963B (en) 1,6- diazabicyclo [3,2,1] octan-7 one derivatives and their use in the treatment of bacterial infections
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
WO2015014993A3 (en) Anti-infective compounds
CL2008001745A1 (es) Compuestos derivados de imidazo[1,2-a]pirazina; composición farmacéutica; y uso de los compuestos como inhibidores de la proteína quinasa en el tratamiento del cáncer.
PT2748165T (pt) Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona e sua utilização no tratamento de infeções bacterianas
CL2011000729A1 (es) Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
CL2011000116A1 (es) Compuestos derivados de imidazo[1,2-a]piridina; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y uso en el tratamiento del cancer.
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UA109557C2 (uk) Похідні 2-піперазин-1-іл-4h-1,3-бензотіазин-4-ону та їх застосування для лікування інфекцій у ссавців
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
CL2009001345A1 (es) Compuestos derivados de 1-piridin-2-il-urea y 1-pirimidin-2-il-urea sustituidos, inhibidores de adn girasa y topoisomerasa iv; composicion farmaceutica; y su uso en tratamiento de infecciones bacterianas como neumonia adquirida intrahospitalariamente, infecciones a la piel, bronquitis, sinusitis, entre otras enfermedades.
UY31864A (es) Derivados de urea hetericíclica y métodos de uso de los mismos-332

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.